A61K36/80

USE OF A MICROALGAE EXTRACT, ALONE OR IN COMBINATION, FOR IMPROVING COGNITIVE ABILITIES
20250352593 · 2025-11-20 ·

The invention relates to the use of an extract of Phaeodactylum tricornutum alone or in combination with an extract chosen from a guarana (Paullinia cupana) extract, a ginseng (Panax ginseng) extract, a Ginkgo biloba extract, a Nelumbo nucifera extract, a Centella asiatica extract, a Piper nigrum extract, a Bacopa monnieri extract or any combination thereof and/or a compound chosen from arginine, creatine, caffeine, theanine, vitamin C, vitamin E, vitamin B, theophylline, paraxanthine, theobromine, rosmarinic acid, ellagic acid, cinnamaldehyde or any combination thereof, for maintaining and/or increasing data processing speed and/or concentration in healthy mammals. The combination of the extract of P. tricornutum and one of these extracts or one of these compounds is also described. The invention also relates to a composition comprising the combination according to the invention.

USE OF A MICROALGAE EXTRACT, ALONE OR IN COMBINATION, FOR IMPROVING COGNITIVE ABILITIES
20250352593 · 2025-11-20 ·

The invention relates to the use of an extract of Phaeodactylum tricornutum alone or in combination with an extract chosen from a guarana (Paullinia cupana) extract, a ginseng (Panax ginseng) extract, a Ginkgo biloba extract, a Nelumbo nucifera extract, a Centella asiatica extract, a Piper nigrum extract, a Bacopa monnieri extract or any combination thereof and/or a compound chosen from arginine, creatine, caffeine, theanine, vitamin C, vitamin E, vitamin B, theophylline, paraxanthine, theobromine, rosmarinic acid, ellagic acid, cinnamaldehyde or any combination thereof, for maintaining and/or increasing data processing speed and/or concentration in healthy mammals. The combination of the extract of P. tricornutum and one of these extracts or one of these compounds is also described. The invention also relates to a composition comprising the combination according to the invention.

Eye-soothing externally-applied liquid medicine and preparation method therefor
12551476 · 2026-02-17 · ·

An eye-soothing externally-applied liquid medicine includes a phase A, a phase B, an adjuvant and purified water. The phase A includes a western medicine component and a traditional Chinese medicine component by mass. The western medicine component includes at least one of 0.1 g of atropine, 0.1 g of homatropine, and 0.1 g of tropicamide. The traditional Chinese medicine component includes at least one of 0.5 g of a cassia seed extract, 0.5 g of a mulberry leaf extract, 0.2 g of a marigold flower extract, 0.5 g of a fibs albiziae extract, 0.5 g of an eyebright extract, and 0.2 g of a common foxglove leaf extract. The phase B includes 1 g of vitamin A, 0.5 g of vitamin B1, 0.005 g of vitamin B2, 0.001 g of vitamin B12, 0.5 g of adenosine triphosphate, 1 g of Vaccinium myrtillus seed oil, and 0.001 g of lutein.

Eye-soothing externally-applied liquid medicine and preparation method therefor
12551476 · 2026-02-17 · ·

An eye-soothing externally-applied liquid medicine includes a phase A, a phase B, an adjuvant and purified water. The phase A includes a western medicine component and a traditional Chinese medicine component by mass. The western medicine component includes at least one of 0.1 g of atropine, 0.1 g of homatropine, and 0.1 g of tropicamide. The traditional Chinese medicine component includes at least one of 0.5 g of a cassia seed extract, 0.5 g of a mulberry leaf extract, 0.2 g of a marigold flower extract, 0.5 g of a fibs albiziae extract, 0.5 g of an eyebright extract, and 0.2 g of a common foxglove leaf extract. The phase B includes 1 g of vitamin A, 0.5 g of vitamin B1, 0.005 g of vitamin B2, 0.001 g of vitamin B12, 0.5 g of adenosine triphosphate, 1 g of Vaccinium myrtillus seed oil, and 0.001 g of lutein.

Eye-soothing externally-applied liquid medicine and preparation method therefor
12551476 · 2026-02-17 · ·

An eye-soothing externally-applied liquid medicine includes a phase A, a phase B, an adjuvant and purified water. The phase A includes a western medicine component and a traditional Chinese medicine component by mass. The western medicine component includes at least one of 0.1 g of atropine, 0.1 g of homatropine, and 0.1 g of tropicamide. The traditional Chinese medicine component includes at least one of 0.5 g of a cassia seed extract, 0.5 g of a mulberry leaf extract, 0.2 g of a marigold flower extract, 0.5 g of a fibs albiziae extract, 0.5 g of an eyebright extract, and 0.2 g of a common foxglove leaf extract. The phase B includes 1 g of vitamin A, 0.5 g of vitamin B1, 0.005 g of vitamin B2, 0.001 g of vitamin B12, 0.5 g of adenosine triphosphate, 1 g of Vaccinium myrtillus seed oil, and 0.001 g of lutein.

FORMULATION FOR IMPROVED BRAIN FUNCTION
20260083784 · 2026-03-26 ·

The invention is a formulation of probiotics and herbal supplements that preserve or improve brain function by preserving or enhancing nerve and brain health and operation.

FORMULATION FOR IMPROVED BRAIN FUNCTION
20260083784 · 2026-03-26 ·

The invention is a formulation of probiotics and herbal supplements that preserve or improve brain function by preserving or enhancing nerve and brain health and operation.

COMPOSITIONS AND METHODS FOR AMELIORATING SYMPTOMS ASSOCIATED WITH INFLAMMATORY SKIN DISORDERS

The present invention is directed to compositions and methods for ameliorating symptoms associated with inflammatory skin disorders involving applying a synergistic blend of plant-based actives containing: (1) a synergistic blend of at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; (c) a biotech-derived Haberlea rhodopensis extract; and (d) Padina pavonica thallus extract; and (2) at least one skin protectant active ingredient.

COMPOSITIONS AND METHODS FOR AMELIORATING SYMPTOMS ASSOCIATED WITH INFLAMMATORY SKIN DISORDERS

The present invention is directed to compositions and methods for ameliorating symptoms associated with inflammatory skin disorders involving applying a synergistic blend of plant-based actives containing: (1) a synergistic blend of at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; (c) a biotech-derived Haberlea rhodopensis extract; and (d) Padina pavonica thallus extract; and (2) at least one skin protectant active ingredient.

Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders

The present invention is directed to compositions and methods for ameliorating symptoms associated with inflammatory skin disorders involving applying a synergistic blend of plant-based actives containing: (1) a synergistic blend of at least: (a) Calendula officinalis stem cell extract; (b) Symphytum officinale extract; (c) a biotech-derived Haberlea rhodopensis extract; and (d) Padina pavonica thallus extract; and (2) at least one skin protectant active ingredient.